首页> 美国卫生研究院文献>Postgraduate Medical Journal >Growth hormone prolactin and thyrotrophin responses to thyrotrophin-releasing hormone in diabetic patients.
【2h】

Growth hormone prolactin and thyrotrophin responses to thyrotrophin-releasing hormone in diabetic patients.

机译:糖尿病患者生长激素催乳激素和促甲状腺激素对促甲状腺激素释放激素的反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Growth hormone (GH), prolactin (PRL) and thyrotrophin (TSH) responses to thyrotrophin-releasing hormone (TRH) were studied in 15 insulin-dependent diabetic patients. Basal plasma GH levels were raised above 5 mu./l in 6 patients and following the injection of TRH there was a significant rise in plasma GH levels in 9. The mean rise in plasma GH from basal to peak values was significant in the group as a whole (P < 0.01). Basal PRL and TSH levels were normal and rose normally in response to TRH. GH release may be qualitatively abnormal in some diabetics and any such loss of specificity of GH-releasing mechanisms would further contribute to the raised GH levels found in many diabetics which would be of importance if GH is a factor in the aetiology of diabetic microangiopathy.
机译:在15位胰岛素依赖型糖尿病患者中研究了生长激素(GH),催乳激素(PRL)和促甲状腺激素(TSH)对促甲状腺激素释放激素(TRH)的反应。 6例患者的基础血浆GH水平升高到5μl/ l以上,注射TRH后9例血浆GH水平显着升高。在该组中,血浆GH从基础水平平均升高到峰值显着。整体(P <0.01)。基础TRL和TSH水平正常,对TRH的反应正常上升。在某些糖尿病患者中,GH的释放可能在质上异常,而这种释放GH的机制的特异性丧失将进一步导致许多糖尿病患者发现GH水平升高,如果GH是糖尿病微血管病病因中的一个因素,这一点将非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号